Clinical Trial Update: Evaluation of Romosozumab vs. Zoledronic Acid Effect in Patients With Spinal Cord Injury and Low Bone Mineral Density [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating romosozumab versus zoledronic acid for osteoporosis with spinal cord injury-related low bone density.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoporosis
• Spinal Cord Injury Related Osteoporosis

Drugs mentioned

• Romosozumab (romosozumab)
• Zoledronic acid (Zoledronic acid)

Snippet

Sponsor: Sheba Medical Center | Conditions: Osteoporosis Fracture, Spinal Cord Injuries | Phase 4 | Status: UNKNOWN